Michael Rosenblatt

Michael Rosenblatt

Chairman of the Research and Development and Production Committee

Dr. Michael Rosenblatt joined the Ferring Board of Directors in July 2024 as Chairman of the Research and Development and Production Committee. He was formerly Chief Medical Officer at Merck & Co., Inc, a Professor of Medicine at Harvard Medical School, and Dean of Tufts University School of Medicine. Before joining Ferring, Dr. Rosenblatt was Chief Medical Officer of the life sciences venture capital company Flagship Pioneering, and served as Director of several of its portfolio companies. During his career, he has also held senior scientific and management roles at a number of biopharmaceutical companies. Dr. Rosenblatt gained his M.D. magna cum laude degree from Harvard University in the U.S.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK